Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Regular exercise before hospitalization significantly improves strength, physical function, and survival rates in older adults with heart failure, highlighting its importance for effective risk ...

Add Yahoo as a preferred source to see more of our stories on Google. Exercise has long been recognized by clinicians, scientists and public health officials as an important way to maintain health ...